- Home
- AQST vs RVNC Comparison
AQST vs RVNC Comparison
Compare AQST & RVNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AQST
- RVNC
- Stock Information
- Founded
- AQST 2004
- RVNC 1999
- Country
- AQST United States
- RVNC United States
- Employees
- AQST N/A
- RVNC N/A
- Industry
- AQST Biotechnology: Pharmaceutical Preparations
- RVNC Biotechnology: Pharmaceutical Preparations
- Sector
- AQST Health Care
- RVNC Health Care
- Exchange
- AQST Nasdaq
- RVNC Nasdaq
- Market Cap
- AQST 502.6M
- RVNC 421.7M
- IPO Year
- AQST 2018
- RVNC 2014
- Fundamental
- Price
- AQST $3.80
- RVNC $3.08
- Analyst Decision
- AQST Strong Buy
- RVNC Hold
- Analyst Count
- AQST 8
- RVNC 9
- Target Price
- AQST $10.38
- RVNC $8.45
- AVG Volume (30 Days)
- AQST 1.5M
- RVNC 3.3M
- Earning Date
- AQST 11-04-2024
- RVNC 11-07-2024
- Dividend Yield
- AQST N/A
- RVNC N/A
- EPS Growth
- AQST N/A
- RVNC N/A
- EPS
- AQST N/A
- RVNC N/A
- Revenue
- AQST $58,900,000.00
- RVNC $256,945,000.00
- Revenue This Year
- AQST $18.45
- RVNC $11.28
- Revenue Next Year
- AQST N/A
- RVNC $27.21
- P/E Ratio
- AQST N/A
- RVNC N/A
- Revenue Growth
- AQST 22.56
- RVNC 25.82
- 52 Week Low
- AQST $1.84
- RVNC $2.30
- 52 Week High
- AQST $6.23
- RVNC $9.75
- Technical
- Relative Strength Index (RSI)
- AQST 36.14
- RVNC 32.88
- Support Level
- AQST $3.56
- RVNC $3.06
- Resistance Level
- AQST $3.92
- RVNC $3.11
- Average True Range (ATR)
- AQST 0.23
- RVNC 0.14
- MACD
- AQST -0.05
- RVNC -0.00
- Stochastic Oscillator
- AQST 13.91
- RVNC 5.60
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Sympazan Oral Film, Suboxone Sublingual Film, Exservan Oral Film, and Zuplenz. The product pipeline includes Libervant Buccal Film, AQST-108, and AQST-305. The majority of its revenue comes from the United States.
About RVNC Revance Therapeutics Inc.
Revance Therapeutics Inc is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. The company has launched a prestige aesthetics portfolio, which includes the RHA Collection of dermal fillers and the HintMD platform. Its main products include DaxibotulinumtoxinA for Injection and DaxibotulinumtoxinA for Injection Aesthetics. The operating business segments are the Product and the Service Segment. The Products segment generates maximum revenue and is engaged in the research and development of aesthetic and therapeutic products.